Description

Ethyl 2-(4-Oxo-1-Phenyl-1,4-Dihydro-5H-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Acetate is a high-purity, advanced pharmaceutical intermediate belonging to the pyrazolopyrimidine class of heterocyclic compounds. This compound is of significant commercial interest for its role as a key building block in the synthesis of active pharmaceutical ingredients (APIs) targeting various therapeutic areas. It is primarily required by pharmaceutical R&D laboratories, contract manufacturing organizations (CMOs), and fine chemical producers engaged in developing novel drug candidates.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug molecules, particularly kinase inhibitors.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the discovery of new bioactive compounds.
• API Synthesis: Serves as a core scaffold for constructing final active pharmaceutical ingredients with potential oncological and anti-inflammatory applications.
• Chemical Reference Standard: Employed as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Custom Synthesis: A starting material for contract research and custom synthesis projects requiring specialized heterocyclic chemistry.

Basic Information

Item	Details
Product Name	Ethyl 2-(4-Oxo-1-Phenyl-1,4-Dihydro-5H-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Acetate
CAS No.	656831-55-9
Molecular Formula	C₁₅H₁₄N₄O₃
Molecular Weight	298.30 g/mol
Synonyms	Ethyl (4-oxo-1-phenyl-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)acetate; 5H-Pyrazolo[3,4-d]pyrimidin-5-acetic acid, 1,4-dihydro-4-oxo-1-phenyl-, ethyl ester; Ethyl 1,4-dihydro-4-oxo-1-phenyl-5H-pyrazolo[3,4-d]pyrimidine-5-acetate; 656831-55-9; Pyrazolopyrimidine derivative; 5-(Ethoxycarbonylmethyl)-1-phenyl-1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
EINECS	Contact for details

Quality Control

Our Ethyl 2-(4-Oxo-1-Phenyl-1,4-Dihydro-5H-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Acetate is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity, to ensure it meets stringent specifications for pharmaceutical intermediate use. Certificates of Analysis (COA) documenting identity, purity, and impurity profiles are available upon request to support your regulatory and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials and sources of ignition. For long-term storage, consider inert gas purging to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.